Event Type
Disclosure
Mandatory
Variant
8-K
. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on December 14, 2023, the Company
. Other Events. On March 14, 2024, the Company issued a press release entitled “Better Therapeutics Announces it will Seek Strategic Alternatives and will be De
Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press Release dated March 14, 2024 104 Cover Page Interactive Data File (embed